Rankings
▼
Calendar
APGE Q3 2022 Earnings — Apogee Therapeutics, Inc. Revenue & Financial Results | Market Cap Arena
APGE
Apogee Therapeutics, Inc.
$4B
Q3 2022 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$0
Gross Profit
$0
Operating Income
-$11M
Net Income
-$20M
EPS (Diluted)
$-0.39
QoQ Revenue Growth
NaN%
Cash Flow
Operating Cash Flow
-$7M
Free Cash Flow
-$7M
Stock-Based Comp.
$0
← FY 2022
All Quarters
Q4 2022 →